Dr. Andrew Brohl, MD
Claim this profileMoffitt Cancer Center
Expert in Skin Cancer
Studies Oral Cancers
19 reported clinical trials
30 drugs studied
Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Oral Cancers
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Andrew Brohl, MD is currently running
IL2 + Ipilimumab and Nivolumab
for Melanoma
The purpose of this study is to find out if the administration of Interleukin-2 concurrently with ipilimumab followed by Nivolumab will result in improved anti-cancer activity and if it is effective for advanced melanoma.
Recruiting1 award Phase 213 criteria
Encorafenib + Binimetinib
for Melanoma
The purpose of this study is to assess rate of disease relapse and hazard rate of disease relapse after neoadjuvant therapy based on the statuses of pathologic complete response or non-pathologic complete response, and postoperative adjuvant therapy.
Recruiting1 award Phase < 17 criteria
More about Andrew Brohl, MD
Clinical Trial Related4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Andrew Brohl, MD has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Avelumab
- Interleukin-2
- Cemiplimab-Rwlc
Breakdown of trials Andrew Brohl, MD has run
Skin Cancer
Oral Cancers
Merkel Cell Carcinoma
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Brohl, MD specialize in?
Andrew Brohl, MD focuses on Skin Cancer and Oral Cancers. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Andrew Brohl, MD currently recruiting for clinical trials?
Yes, Andrew Brohl, MD is currently recruiting for 8 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Andrew Brohl, MD has studied deeply?
Yes, Andrew Brohl, MD has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Andrew Brohl, MD?
Apply for one of the trials that Andrew Brohl, MD is conducting.
What is the office address of Andrew Brohl, MD?
The office of Andrew Brohl, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.